Medtech Exits, Funding Prospects Are Getting Better
This article was originally published in Clinica
Executive Summary
Venture-backed medtech companies looking for investment, particularly if they are later stage concerns seeking growth capital, may find the fundraising climate far more favorable now than it has been for some time.